ArticleCellular and molecular life sciences : CMLS2024

Amiloride sensitizes prostate cancer cells to the reversible tyrosine kinase inhibitor lapatinib by modulating Erbb3 subcellular localization.

Maitreyee K Jathal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.